Influenza virus vaccine - AVANT Immunotherapeutics/Sanofi
Latest Information Update: 04 Apr 2022
At a glance
- Originator sanofi pasteur
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 05 Jun 2002 Discontinued - Phase-I for Influenza virus infections in France (IM)
- 05 Jun 2002 Discontinued - Phase-II for Influenza virus infections in Peru (IM)
- 24 Dec 1999 Pasteur Mérieux Connaught is now a subsidiary of Aventis and its new name is Aventis Pasteur